DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

Information source: AstraZeneca
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Chronic Obstructive Pulmonary Disease

Phase: N/A

Status: Active, not recruiting

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
Shigeru Yoshida, MD, Study Director, Affiliation: Astrazeneca KK

Summary

The purpose of the investigation is to confirm the safety and efficacy in long-term use of Symbicort Turbuhaler in patients with Chronic obstructive pulmonary disease (COPD) under the post-marketing actual use.

Clinical Details

Official title: Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for COPD Patients

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Adverse event incidence

Secondary outcome: Clinical questionnaire about chronic obstructive pulmonary disease(CCQ)

Detailed description: Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for COPD patients

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Among patients treated with Symbicort Turbuhaler due to chronic obstructive pulmonary

disease(COPD), those who received the drug for the first time.

Locations and Contacts

Research Site, Aichi, D589dl00001, Japan

Research Site, Akita, D589dl00001, Japan

Research Site, Aomori, D589dl00001, Japan

Research Site, Chiba, D589dl00001, Japan

Research Site, Ehime, D589dl00001, Japan

Research Site, Fukui, D589dl00001, Japan

Research Site, Fukuoka, D589dl00001, Japan

Research Site, Fukushima, D589dl00001, Japan

Research Site, Gifu, D589dl00001, Japan

Research Site, Gunma, D589dl00001, Japan

Research Site, Hiroshima, D589dl00001, Japan

Research Site, Hokkaido, D589dl00001, Japan

Research Site, Hyogo, D589dl00001, Japan

Research Site, Ibaraki, D589dl00001, Japan

Research Site, Ishikawa, D589dl00001, Japan

Research Site, Iwate, D589dl00001, Japan

Research Site, Kagawa, D589dl00001, Japan

Research Site, Kagoshima, D589dl00001, Japan

Research Site, Kanagawa, D589dl00001, Japan

Research Site, Kochi, D589dl00001, Japan

Research Site, Kumamoto, D589dl00001, Japan

Research Site, Kyoto, D589dl00001, Japan

Research Site, Mie, D589dl00001, Japan

Research Site, Miyagi, D589dl00001, Japan

Research Site, Miyazaki, D589dl00001, Japan

Research Site, Nagano, D589dl00001, Japan

Research Site, Nagasaki, D589dl00001, Japan

Research Site, Nara, D589dl00001, Japan

Research Site, Niigata, D589dl00001, Japan

Research Site, Oita, D589dl00001, Japan

Research Site, Okayama, D589dl00001, Japan

Research Site, Okinawa, D589dl00001, Japan

Research Site, Osaka, D589dl00001, Japan

Research Site, Saga, D589dl00001, Japan

Research Site, Saitama, D589dl00001, Japan

Research Site, Shiga, D589dl00001, Japan

Research Site, Shimane, D589dl00001, Japan

Research Site, Shizuoka, D589dl00001, Japan

Research Site, Tochigi, D589dl00001, Japan

Research Site, Tokushima, D589dl00001, Japan

Research Site, Tokyo, D589dl00001, Japan

Research Site, Tottori, D589dl00001, Japan

Research Site, Toyama, D589dl00001, Japan

Research Site, Wakayama, D589dl00001, Japan

Research Site, Yamagata, D589dl00001, Japan

Research Site, Yamaguchi, D589dl00001, Japan

Research Site, Yamanashi, D589dl00001, Japan

Additional Information

Starting date: November 2012
Last updated: July 15, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017